NCT03595631 is a NA clinical trial of Physical Therapy in Multiple Sclerosis, sponsored by Universidad Rey Juan Carlos.

Who is sponsoring NCT03595631?

NCT03595631 is sponsored by Universidad Rey Juan Carlos.

What drugs are being tested in NCT03595631?

Interventions in NCT03595631: Physical Therapy, Physical Therapy plus Neurodynamic.

What condition does NCT03595631 study?

NCT03595631 studies Multiple Sclerosis.

Is NCT03595631 still recruiting?

NCT03595631 is currently completed. Last updated 22 October 2018.

Last reviewed 2018-10-22 · How we verify

NCT03595631

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Neurodynamic Interventions for Multiple Sclerosis

Completed NA Last updated 22 October 2018

What this trial tests

NA trial testing Physical Therapy in Multiple Sclerosis in 32 participants. Completed in 4 October 2018.

Timeline

26 July 2018

Primary endpoint
15 September 2018

4 October 2018

Quick facts

Lead sponsor	Universidad Rey Juan Carlos
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	32
Start date	26 July 2018
Primary completion	15 September 2018
Estimated completion	4 October 2018
Sites	1 location across Spain

Drugs / interventions tested

Physical Therapy
Physical Therapy plus Neurodynamic

Conditions studied

Multiple Sclerosis — all drugs for Multiple Sclerosis →

Sponsor

Universidad Rey Juan Carlos — full company profile →

Who can join

Adults 18 to 65, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomized, parallel-group, clinical trial will be conducted to compare the immediate effects of the inclusion of a neurodynamic intervention into a multimodal physiotherapy program on pressure pain sensitivity, pain and manual dexterity in patients with multiple sclerosis

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effects of neurodynamic interventions on pain sensitivity and function in patients with multiple sclerosis: a randomized clinical trial.
de Dios Pérez-Bruzón J, Fernández-de-Las-Peñas C, Cleland JA, Plaza-Manzano G, et al · · 2022 · cited 2× · PMID 35101724 · DOI 10.1016/j.physio.2021.04.004

Verify or expand the search:

Other trials of Physical Therapy

Trials testing the same drug.

NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, · NA · not yet recruiting
NCT05670080 — Does MI Have a Therapeutic Role in Arthroscopic Rotator Cuff Repair? · NA · suspended
NCT07296770 — An Artificial Intelligence Driven Approach to Optimize Patient Selection for a Transitional Pain Service · Phase 3 · not yet recruiting
NCT07471100 — Neuromodulation-Induced Cortical Prehabilitation in High Grade Glioma Near the Motor Pathway: Cortical Plasticity Assess · NA · not yet recruiting
NCT07376811 — Effect Of Sleeping Posture Guidance On Sleep Quality In Patients With Rotator Cuff Syndrome · NA · not yet recruiting

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting

Other Universidad Rey Juan Carlos trials

Trials by the same sponsor.

NCT07524400 — Effects of Physical Exercise Combined With Transcranial Direct Current Stimulation in Parkinson's Disease · NA · recruiting
NCT07402902 — Caffeine Strategies and Fat Oxidation · NA · not yet recruiting
NCT07251738 — Understanding the Lived Experience and Bereavement of Caregivers of People With Alzheimer's Disease · not yet recruiting
NCT07247760 — PATIENT SATISFACTION AND MASKING OF WHITE SPOT LESIONS AFTER HOME WHITENING WITH 10% CARBAMIDE PEROXIDE · NA · enrolling by invitation
NCT06968676 — Mixed Reality for Upper Limb Rehabilitation in People With Multiple Sclerosis (VIRTUALDOMUS) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03595631 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad Rey Juan Carlos
Last refreshed: 22 October 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03595631.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing